MediciNova, Inc. (MNOV)
1.64
+0.04
(+2.50%)
USD |
NASDAQ |
Feb 09, 16:00
1.65
+0.01
(+0.61%)
Pre-Market: 20:00
MediciNova Profit Margin (Quarterly) : -2.47K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.18% |
| Return on Assets | -22.76% |
| Return on Invested Capital | -24.01% |
| Gross Profit Margin (Quarterly) | -31.63% |
| Operating Margin (Quarterly) | -2.74K% |
| Return on Net Operating Assets | -81.37% |